Larvol Delta - Efficacy-and-Safety-of-VB119-in-Subjects-With-Minimal-Change-Disease-MCD-and-Focal-Segmental-Glomerulosclerosis-FSGS

VB119 - ValenzaBio

http://clinicaltrials.gov/ct2/show/NCT05441826

Jan 13, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next